| Cheryl Wellington Department of Pathology and Laboratory Medicine, University of British Columbia |
||
| Biography | ||
Dr. Wellington obtained her PhD in Microbiology at the University of British Columbia in 1991 and did postdoctoral training at Harvard Medical School, the University of Calgary, and the University of British Columbia. She joined the Department of Pathology and Laboratory Medicine at the University of British Columbia in 2000 and was promoted to Professor in 2011. Dr. Wellington is a basic research scientist whose research interests focus on three common genetic and environmental risk factors for dementia, including apolipoprotein E (apoE) metabolism, history of traumatic brain injury (TBI), and cerebrovascular dysfunction. |
||
| Research Interest | ||
Traumatic brain injury, Alzheimer Disease,neuropathology and clinical presentation of TBI-related syndromes, Neuroscience, Neurology, Meurodegenrative disorder |
||